Aktie A185490 EYEGENE INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen EyeGene Inc.

Aktien

A185490

KR7185490000

A185490

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 14.05.2024 		% 5 Tage % 1. Jan.
2 995 KRW -0,50 % Intraday Chart für EyeGene Inc. -2,28 % -29,78 %
2023 EyeGene Inc. meldet Ergebnis für das erste Quartal zum 31. März 2023 CI
2023 EyeGene Inc. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.
EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.
EyeGene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
EyeGene Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index
Maravai LifeSciences : Says Unit TriLink To Supply Proprietary Technology to EyeGene for Production of COVID-19 Vaccine
EyeGene Inc.(KOSDAQ:A185490) added to S&P Global BMI Index
EyeGene Inc. announced that it has received KRW 22 billion in funding from a group of investors
EyeGene Inc. announced that it expects to receive KRW 22 billion in funding from a group of investors
EyeGene Inc.(KOSDAQ:A185490) dropped from S&P Global BMI Index
EyeGene Inc. announced that it has received KRW 29.9998664 billion in funding from Meritz Securities Co., Ltd., Investment Arm, IBK Capital Corporation, Korea Investment & Securities Co., Ltd., Investment Arm
EyeGene Inc. announced that it expects to receive KRW 29.9998664 billion in funding from a group of investors
EyeGene Inc. announced that it has received KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.
EyeGene Inc. announced that it has received KRW 12.6 billion in funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc.
EyeGene Inc. announced that it expects to receive funding from Korea Investment Partners Co. Ltd., G.N.TECH Venture Capital Co., Ltd., DSC Investment Inc. and other investors
EyeGene Inc. announced that it expects to receive KRW 5.4 billion in funding from DSC Investment Inc., G.N.TECH Venture Capital Co., Ltd., Korea Investment Partners Co. Ltd.
EyeGene, Inc.(XKON:A185490) added to S&P Global BMI Index
EyeGene, Inc. completed the sale of ICM co., Ltd.
EyeGene, Inc. agreed to sell ICM co., Ltd for KRW 90 million.
LB Investment Inc. through its fund LB Gemini New Growth Fund 16 acquired an unknown stake in EyeGene, Inc. from KoFC-Hanwha Pioneer Champ 2010 Fund 14 and 09-4 Hanwha Venture Investment Partnership, funds of Hanwha Investment Corp for KRW 1.7 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A185490 Aktie
  4. Nachrichten EyeGene Inc.
  5. Andere Sprachen